Combination of suberoylanilide hydroxamic acid and ritonavir is effective against renal cancer cells

Urology

Volumn 76, Issue 3, 2010, Pages 764.e7-764.e13

  Sato, Akinori ^a   Asano, Takako ^a   Horiguchi, Akio ^a   Ito, Keiichi ^a   Sumitomo, Makoto ^a   Asano, Tomohiko ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HISTONE; RITONAVIR; VORINOSTAT; ANTINEOPLASTIC AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; HYDROXAMIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; HUMAN; HUMAN CELL; KIDNEY CANCER; PRIORITY JOURNAL; UBIQUITINATION; WESTERN BLOTTING; DRUG COMBINATION; DRUG SCREENING; KIDNEY NEOPLASMS; PATHOLOGY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG THERAPY, COMBINATION; HIV PROTEASE INHIBITORS; HYDROXAMIC ACIDS; KIDNEY NEOPLASMS; RITONAVIR; TUMOR CELLS, CULTURED;

EID: 84755161697     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.04.042     Document Type: Article

References (30)

1. R.J. Motzer, N.H. Bander, and D.M. Nanus Renal-cell carcinoma N Engl J Med 335 1996 865 875
2. B. Escudier, T. Eisen, and W.M. Stadler Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 2007 125 134
3. M.J. Ratain, T. Eisen, and W.M. Stadler Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma J Clin Oncol 24 2006 2505 2512 (Pubitemid 46630627)
4. T.H. Luu, R.J. Morgan, and L. Leong A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study Clin Cancer Res 14 2008 7138 7142
5. J. Vansteenkiste, E. Van Cutsem, and H. Dumez Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer Invest New Drugs 26 2008 483 488
6. G.R. Blumenschein Jr., M.S. Kies, and V.A. Papadimitrakopoulou Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer Invest New Drugs 26 2008 81 87
7. A.M. Traynor, S. Dubey, and J.C. Eickhoff Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study J Thorac Oncol 4 2009 522 526
8. S. Kumar, C.S. Bryant, and S. Chamala Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells Mol Cancer 8 2009 26
9. M.Z. Dewan, M. Tomita, and H. Katano An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells Int J Cancer 124 2009 622 629
10. M. Kraus, E. Malenke, and J. Gogel Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis Mol Cancer Ther 7 2008 1940 1948
11. S. Emanuele, M. Lauricella, and D. Carlisi SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor bortezomib Apoptosis 12 2007 1327 1338
12. U. Heider, I. von Metzler, and M. Kaiser Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma Eur J Haematol 80 2008 133 142
13. L.L. Vindelov, I.J. Christensen, and N.I. Nissen A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis Cytometry 3 1983 323 327
14. H. Lehrmann, L.L. Pritchard, and A. Harel-Bellan Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation Adv Cancer Res 86 2002 41 65
15. P.A. Wade Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin Hum Mol Genet 10 2001 693 698
16. S. Thiagalingam, K.H. Cheng, and H.J. Lee Histone deacetylases: unique players in shaping the epigenetic histone code Ann NY Acad Sci 983 2003 84 100
17. W.S. Xul, R.B. Parmigiani, and P.A. Marks Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 26 2007 5541 5552
18. W.D. Cress, and E. Seto Histone deacetylases, transcriptional control, and cancer J Cell Physiol 184 2000 1 16
19. S. Timmermann, H. Lehrmann, and A. Polesskaya Histone acetylation and disease Cell Mol Life Sci 58 2001 728 736
20. C.B. Yoo, and P.A. Jones Epigenetic therapy of cancer: past, present and future Nat Rev Drug Discov 5 2006 37 50
21. V.M. Richon, Y. Webb, and R. Merger Second generation hybrid polar compounds are potent inducers of transformed cell differentiation Proc Natl Acad Sci U S A 93 1996 5705 5708
22. V.M. Richon, T.W. Sandhoff, and R.A. Rifkind Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation Proc Natl Acad Sci U S A 97 2000 10014 10019
23. P. Bali, M. Pranpat, and R. Swaby Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of Her-2 Clin Cancer Res 11 2005 6382 6389
24. M.Z. Dewan, J. Uchihara, and K. Terashima Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir Blood 107 2006 716 724
25. A. Sato, M. Oya, and K. Ito Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor 1, interferon-gamma and a novel NF-kappaB inhibitor Int J Oncol 28 2006 841 846
26. U. Ramp, T. Krieg, and E. Caliskan XIAP expression is an independent prognostic marker in clear-cell renal carcinomas Hum Pathol 35 2004 1022 1028
27. A. Hrzenjak, F. Moinfar, and M.L. Kremser Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells Mol Cancer Ther 5 2006 2203 2210
28. C.Y. Gui, L. Ngo, and W.S. Xu Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1 Proc Natl Acad Sci U S A 101 2004 1241 1246
29. H. Caron, B. van Schaik, and M. van derMee The human transcriptome map: clustering of highly expressed genes in chromosomal domains Science 291 2001 1289 1292
30. M.A. Glozak, N. Sengupta, and X. Zhang Acetylation and deacetylation of non-histone proteins Gene 363 2005 15 23